Background and Purpose-The apolipoprotein B (apoB)/apoAI ratio is recognized as a better indicator of cardiovascular disease than other cholesterol measures. Whether intracranial or extracranial atherosclerosis is more closely associated with an increased apoB/apoAI ratio has not been investigated. Methods-A total of 464 statin or fibrate naïve Korean patients with acute ischemic stroke was categorized into 3 groups:intracranial (ICAS, nϭ236), extracranial (nϭ44), and no cerebral atherosclerotic stenosis (nϭ184). The apoB/apoAI ratio and demographics, including the presence of metabolic syndrome, were compared among the groups. Results-The ICAS group showed a higher apoB/apoAI ratio (0.81Ϯ0.02) than both the extracranial atherosclerotic stenosis (0.74Ϯ0.03) and no cerebral atherosclerotic stenosis (0.72Ϯ0.02) groups (Pϭ0.002). The ratio was substantially increased (0.93Ϯ0.03) in patients with advanced ICAS (Ն3 intracranial stenoses). With a multivariable analysis, the highest apoB/apoAI ratio quartile was an independent predictor of ICAS (OR, 2.13; 95% CI, 1.05 to 4.33).A dose-response relationship was observed between the presence of advanced ICAS and the apoB/apoAI ratio quartiles (OR, 4.03; 95% CI, 1.26 to 12.88 for the second quartile; OR, 4.88; 95% CI, 1.54 to 15.49 for the third quartile; and OR, 7.79; 95% CI, 2.41 to 25.16 for the fourth quartile when referenced to the first quartile). Patients having more metabolic syndrome components were more likely to have ICAS, advanced ICAS, and a higher apoB/apoAI ratio (PϽ0.001 for all). Conclusions-A higher apoB/apoAI ratio is a predictor of ICAS rather than of extracranial atherosclerotic stenosis or no cerebral atherosclerotic stenosis. The apoB/apoAI ratio might be a biomarker for ICAS in Asian patients with stroke. (Stroke. 2011;42:3040-3046.)